BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203.
Márquez-Rodas I, Dutriaux C, Saiag P, de la Cruz Merino L, Castañón Álvarez E, Robert C, Rodríguez-Moreno JF, Arance A, Cerezuela-Fuentes P, Montaudié H, Sanmamed MF, González-Cao M, Charles J, López Criado MP, Berrocal A, de Miguel E, Funck-Brentano E, Prey S, Álamo de la Gala MC, Melero I, Avilés-Izquierdo JA, Roman R, Garcia-Pelaez B, Rodriguez S, Trnkova ZJ, Quintero M, Maciá S, Chaney MF, Dalle S.
Márquez-Rodas I, et al. Among authors: rodriguez s.
J Clin Oncol. 2025 Jun 27:JCO2402595. doi: 10.1200/JCO-24-02595. Online ahead of print.
J Clin Oncol. 2025.
PMID: 40577656